EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mitochondrial metabolism related markers GDF‐15, FGF‐21, and HIF‐1α are elevated in pediatric migraine attacks

Yasemin Baranoglu Kilinc, Erkan Kilinc iD, Aysegul Danis, Fatma Hanci, Sevim Turay, Aynur Ozge, Hayrunnisa Bolay iD

Headache: The Journal of Head and Face Pain · 2023-09 · 63 (8) · 1076-1086

DOI: 10.1111/head.14618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 19.08.2023. Verfasst von Yasemin Baranoglu Kilinc und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Bolu Izzet Baysal State Hospital, Bolu, Turkey. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Calcitonin Gene-Related Peptide. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gazi University, Turkish Academy of Sciences (TUBA), Gazi Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The purpose of this study was to investigate the serum levels of mitochondrial metabolism/reactive oxygen species (ROS)–related peptides (hypoxia inducible factor‐1α [HIF‐1α], fibroblast growth factor‐21 [FGF‐21], growth differentiation factor‐15 [GDF‐15]) and key migraine‐related neuropeptides (calcitonin gene–related peptide [CGRP], pituitary adenylate cyclase‐activating peptide‐38 [PACAP‐38], substance P [SP], and vasoactive intestinal peptide [VIP]) during migraine attacks and to evaluate their diagnostic value in pediatric migraine.

Background

There is increasing evidence for the important role of impairment in oxidative mitochondrial metabolism in the pathophysiology of migraine. Potential biomarkers that may reflect the relationship between migraine and mitochondrial dysfunction are unclear.

Methods

A total of 68 female pediatric migraine patients without aura and 20 female healthy controls aged 8–18 years, admitted to the hospital, were enrolled in this cross‐sectional study. Serum concentrations of these molecules were determined by enzyme‐linked immunosorbent assays, and clinical features and their possible diagnostic value were analyzed.

Results

Serum levels of HIF‐1α (252.4 ± 51.9 [mean ± standard deviation]) pg/mL), GDF‐15 (233.7 ± 24.7 pg/mL), FGF‐21 (96.1 ± 13.1 pg/mL), CGRP (44.5 ± 11.3), and PACAP‐38 (504.7 ± 128.9) were significantly higher in migraine patients compared to healthy controls (199.8 ± 26.8, 192.8 ± 20.7, 79.3 ± 4.1, 34.1 ± 3.5 and 361.2 ± 86.3 pg/mL, respectively). The serum levels of these peptides were also higher in patients with chronic migraine than in patients with episodic migraine, and higher in the ictal period than in the interictal period. A positive correlation was found between attack frequency and both HIF‐1α and FGF‐21 levels in migraine patients. Serum levels of VIP and SP were not different between the migraine patients and healthy controls.

Conclusion

Migraine attacks are accompanied by elevated HIF‐1α, FGF‐21, GDF‐15, CGRP, and PACAP‐38 in medication‐naive pediatric patients with migraine. Elevated circulating mitochondrial metabolism/ROS‐related peptides suggest a mitochondrial stress in pediatric migraine attacks and may have potential diagnostic value in monitoring disease progression and treatment response in children. Novel approaches intervening with mitochondrial metabolism need to be investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Differentiation Factor 15Calcitonin Gene-Related PeptideHumansChildFemaleCross-Sectional StudiesPituitary Adenylate Cyclase-Activating PolypeptideReactive Oxygen SpeciesFibroblast Growth FactorsMitochondria

Stichwörter der Autor:innen

FGF-21GDF-15HIF-1αmitochondrial metabolismpediatric migrainevasoactive neuropeptides

Substanzen

fibroblast growth factor 21Growth Differentiation Factor 15Calcitonin Gene-Related PeptidePituitary Adenylate Cyclase-Activating PolypeptideReactive Oxygen SpeciesFibroblast Growth Factors

Autor:innen und Institutionen

  • Department of Pediatrics, Bolu Izzet Baysal State Hospital, Bolu, Turkey.
  • Department of Physiology, Bolu Abant Izzet Baysal University, Medical Faculty, Bolu, Turkey.
  • Department of Child Neurology, Bolu Abant Izzet Baysal University, Bolu, Turkey.
  • Department of Child Neurology, Duzce University, Bolu, Turkey.
  • Department of Neurology, Mersin University, Medical Faculty, Mersin, Turkey.
  • Department of Neurology and Algology, Neuroscience and Neurotechnology Center NÖROM, Gazi University, Ankara, Turkey.

ORCID-Profile: Erkan Kilinc, Hayrunnisa Bolay

Förderung

  • Gazi University
  • Turkish Academy of Sciences (TUBA)
  • Gazi Üniversitesi
  • Türkiye Bilimler Akademisi

Zitieren

APA

Kilinc, Y. B., Kilinc, E., Danis, A., Hanci, F., Turay, S., Ozge, A., & Bolay, H. (2023). Mitochondrial metabolism related markers GDF‐15, FGF‐21, and HIF‐1α are elevated in pediatric migraine attacks. Headache: The Journal of Head and Face Pain, 63(8), 1076-1086. https://doi.org/10.1111/head.14618

Vancouver

Kilinc YB, Kilinc E, Danis A, Hanci F, Turay S, Ozge A, et al. Mitochondrial metabolism related markers GDF‐15, FGF‐21, and HIF‐1α are elevated in pediatric migraine attacks. Headache: The Journal of Head and Face Pain. 2023;63(8):1076-1086. doi:10.1111/head.14618

BibTeX
@article{Kilinc2023,
  author = {Kilinc, Yasemin Baranoglu and Kilinc, Erkan and Danis, Aysegul and Hanci, Fatma and Turay, Sevim and Ozge, Aynur and Bolay, Hayrunnisa},
  title = {Mitochondrial metabolism related markers GDF‐15, FGF‐21, and HIF‐1α are elevated in pediatric migraine attacks},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2023},
  volume = {63},
  number = {8},
  pages = {1076--1086},
  doi = {10.1111/head.14618}
}
Kostenlos starten →